Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity - Monte Carlo simulation valuation methodology (Detail)

v3.8.0.1
Stockholders’ Equity - Monte Carlo simulation valuation methodology (Detail)
9 Months Ended
Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00%
Maximum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 7 years
Minimum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 5 years
Mustang Bio, Inc [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 77.30%
Mustang Bio, Inc [Member] | Maximum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 2.38%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 10 years
Mustang Bio, Inc [Member] | Minimum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1.81%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 5 years 6 months